SAINT-GERMAIN PHARMA LTD
Wholesale of pharmaceutical goods
SAINT-GERMAIN PHARMA LTD
Wholesale of pharmaceutical goods
Contact & Details
Contact
Registered Address
Linden House Linden Close Tunbridge Wells Kent TN4 8HH United Kingdom
Full company profile for SAINT-GERMAIN PHARMA LTD (10218474), an active company based in Tunbridge Wells, United Kingdom. Incorporated 7 Jun 2016. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2025)
Cash in Bank
N/A
Net Assets
£305.04k
Total Liabilities
£162.95k
Turnover
N/A
Employees
1
Debt Ratio
35%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Andrew Simon Michael Dean | Director | British | United Kingdom | 7 Jun 2016 | Active |
| Condon, Richard Michael | Director | British | England | 1 Oct 2025 | Active |
| May, Jonathan Charles | Director | British | England | 1 Oct 2025 | Active |
See all 4 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Present Value Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent
Aspire Pharma Limited
Unknown
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 2 Oct 2025 | Officers | Appointment of Mr Richard Michael Condon as director on 1 Oct 2025 | |
| 2 Oct 2025 | Officers | Appointment of Mr Gary David Buckley as director on 1 Oct 2025 | |
| 2 Oct 2025 | Persons With Significant Control | Aspire Pharma Limited notified as a person with significant control | |
| 2 Oct 2025 | Persons With Significant Control | Cessation of Present Value Limited as a person with significant control on 1 Oct 2025 | |
| 2 Oct 2025 | Officers | Termination of Andrew Simon Michael Dean as director on 1 Oct 2025 |
Appointment of Mr Richard Michael Condon as director on 1 Oct 2025
Appointment of Mr Gary David Buckley as director on 1 Oct 2025
Aspire Pharma Limited notified as a person with significant control
Cessation of Present Value Limited as a person with significant control on 1 Oct 2025
Termination of Andrew Simon Michael Dean as director on 1 Oct 2025
Recent Activity
Latest Activity
Appointment of Mr Richard Michael Condon as director on 1 Oct 2025
7 months ago on 2 Oct 2025
Appointment of Mr Gary David Buckley as director on 1 Oct 2025
7 months ago on 2 Oct 2025
Aspire Pharma Limited notified as a person with significant control
7 months ago on 2 Oct 2025
Cessation of Present Value Limited as a person with significant control on 1 Oct 2025
7 months ago on 2 Oct 2025
Termination of Andrew Simon Michael Dean as director on 1 Oct 2025
7 months ago on 2 Oct 2025